Unfractionated Croton Lechleri Latex Against Resistant Skin Bacteria
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current treatments for bacterial colonization or primary or secondary bacterial infections of underlying skin disorders, particularly those caused by resistant strains like MRSA, lack effective topical antibiotics, leading to increasing drug resistance and treatment gaps.
Innovation Solution
A novel pharmaceutical composition comprising unfractionated latex of Croton lechleri Müll. Arg., specifically formulated to provide broad-spectrum antibacterial activity against both gram-positive and gram-negative pathogens, including MRSA, through a multi-target therapeutic approach.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional topical antibiotics are used to treat bacterial infections, then initial treatment effectiveness is achieved, but drug resistance develops leading to treatment failure
Solution Approach 1:
The patent segments the antibacterial action into multiple independent targets by using a complex mixture of natural compounds from Croton lechleri latex rather than a single antibiotic agent. This multi-component formulation simultaneously attacks bacterial cells through various mechanisms (cell membrane disruption, protein synthesis inhibition, metabolic interference), making it difficult for bacteria to develop resistance to all targets simultaneously.
Solution Approach 2:
The invention uses a composite material approach by formulating a pharmaceutical composition containing multiple natural compounds extracted from Croton lechleri latex. This composite formulation includes various phenolic compounds, flavonoids, and other bioactive molecules that work synergistically to provide broad-spectrum antibacterial activity while reducing the risk of resistance development compared to single-agent antibiotics.
2Adaptability or versatility
If broad-spectrum antibiotics are used to cover multiple pathogens, then coverage of resistant strains is improved, but side effects and disruption of normal flora increase
Solution Approach 1:
The patent applies parameter changes by using natural compounds from a specific botanical source (Croton lechleri) with defined chemical composition parameters. The formulation achieves broad-spectrum activity through the specific profile of phenolic compounds, flavonoids, and other constituents present in the latex, providing versatility against multiple pathogen types while maintaining a safer side effect profile due to the natural origin and synergistic interactions among components.
3Reliability
If topical formulations are applied to infected skin, then direct treatment of the infection is achieved, but penetration through compromised skin barrier is reduced
Solution Approach 1:
The invention addresses skin penetration issues by utilizing the specific physicochemical parameters of natural compounds extracted from Croton lechleri latex. These compounds possess inherent properties that facilitate penetration through compromised skin barriers, allowing the formulation to effectively reach and treat infections in the skin layers even when the skin barrier is damaged or inflamed.
Data Source
AI summary
The present disclosure provides for a method of treating a bacterial colonization or primary or secondary bacterial infection of an underlying skin disorder in a subject via the topical administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Additionally the present disclosure provides for a method of treating a bacterial colonization or primary or secondary bacterial infection of the nasal mucosa in a subject via the nasal administration of a pharmaceutical composition comprising a therapeutically effective amount of an extract of the Croton lechleri tree. Also provided are details of studies on the effectiveness of an extract of the Croton lechleri tree on bacterial pathogens.